Literature DB >> 30287620

Significant hemolysis is not required for thrombosis in paroxysmal nocturnal hemoglobinuria.

Morag Griffin1, Peter Hillmen2, Talha Munir2, Stephen Richards2, Louise Arnold2, Kathryn Riley2, Anita Hill2.   

Abstract

Entities:  

Year:  2018        PMID： 30287620      PMCID： PMC6395336          DOI： 10.3324/haematol.2018.198846

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria.

Authors:  Jan Simak; Karel Holada; Antonio M Risitano; Jan H Zivny; Neal S Young; Jaroslav G Vostal
Journal:  Br J Haematol       Date:  2004-06       Impact factor: 6.998

2.  Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanisms.

Authors:  Travis J Gould; Trang T Vu; Laura L Swystun; Dhruva J Dwivedi; Safiah H C Mai; Jeffrey I Weitz; Patricia C Liaw
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-07-10       Impact factor: 8.311

3.  Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia.

Authors:  B Hugel; G Socié; T Vu; F Toti; E Gluckman; J M Freyssinet; M L Scrobohaci
Journal:  Blood       Date:  1999-05-15       Impact factor: 22.113

4.  Under-recognized complications in patients with paroxysmal nocturnal haemoglobinuria: raised pulmonary pressure and reduced right ventricular function.

Authors:  Anita Hill; Robert J Sapsford; Andrew Scally; Richard Kelly; Stephen J Richards; Gus Khurisgara; Mohan U Sivananthan; Peter Hillmen
Journal:  Br J Haematol       Date:  2012-05-29       Impact factor: 6.998

Review 5.  Thrombosis in paroxysmal nocturnal hemoglobinuria.

Authors:  Anita Hill; Richard J Kelly; Peter Hillmen
Journal:  Blood       Date:  2013-04-22       Impact factor: 22.113

6.  Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria.

Authors:  Peter Hillmen; Petra Muus; Ulrich Dührsen; Antonio M Risitano; Jörg Schubert; Lucio Luzzatto; Hubert Schrezenmeier; Jeffrey Szer; Robert A Brodsky; Anita Hill; Gerard Socié; Monica Bessler; Scott A Rollins; Leonard Bell; Russell P Rother; Neal S Young
Journal:  Blood       Date:  2007-08-16       Impact factor: 22.113

Review 7.  The prothrombotic state in paroxysmal nocturnal hemoglobinuria: a multifaceted source.

Authors:  Barnaby Peacock-Young; Fraser L Macrae; Darren J Newton; Anita Hill; Robert A S Ariëns
Journal:  Haematologica       Date:  2017-12-15       Impact factor: 9.941

8.  Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry.

Authors:  Jong Wook Lee; Jun Ho Jang; Jin Seok Kim; Sung-Soo Yoon; Je-Hwan Lee; Yeo-Kyeoung Kim; Deog-Yeon Jo; Jooseop Chung; Sang Kyun Sohn
Journal:  Int J Hematol       Date:  2013-05-01       Impact factor: 2.490

Review 9.  Cerebral venous thrombosis in paroxysmal nocturnal hemoglobinuria: a series of 15 cases and review of the literature.

Authors:  Elodie Meppiel; Isabelle Crassard; Régis Peffault de Latour; Sophie de Guibert; Louis Terriou; Hugues Chabriat; Gérard Socié; Marie-Germaine Bousser
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

10.  Paroxysmal Nocturnal Hemoglobinuria (Pnh): Brain Mri Ischemic Lesions In Neurologically Asymtomatic Patients.

Authors:  Wilma Barcellini; Elisa Scola; Silvia Lanfranconi; Marika Grottaroli; Francesca Binda; Bruno Fattizzo; Anna Zaninoni; Gloria Valcamonica; Claudia Maria Cinnante; Carla Boschetti; Massimiliano Buoli; Carlo Alfredo Altamura; Nereo Bresolin; Fabio Triulzi; Alberto Zanella; Agostino Cortelezzi
Journal:  Sci Rep       Date:  2018-01-11       Impact factor: 4.379
View more
  2 in total

1.  Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience.

Authors:  Deniz Goren Sahin; Olga Meltem Akay; Muzaffer Keklik; Vahap Okan; Abdullah Karakus; Cengiz Demir; Mehmet Ali Erkurt; Kadir Ilkkilic; Rahsan Yildirim; Gulsum Akgun Cagliyan; Salih Aksu; Mehmet Hilmi Dogu; Mehmet Sinan Dal; Volkan Karakus; Ali Ihsan Gemici; Hatice Terzi; Engin Kelkitli; Serdar Sivgin; Ali Unal; Mehmet Yilmaz; Orhan Ayyildiz; Serdal Korkmaz; Bulent Eser; Fevzi Altuntas
Journal:  Ann Hematol       Date:  2021-05-14       Impact factor: 3.673

Review 2.  When does a PNH clone have clinical significance?

Authors:  Daria V Babushok
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.